What is AI Optics?
AI Optics has developed innovative handheld imaging technology combined with AI-based disease screening software modules to revolutionize eye care diagnostics. Their FDA-cleared Sentinel Camera captures digital images of the human eye, while their upcoming Sentinel Pro system is designed to identify and diagnose various retinal conditions including Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma.
The company's mission addresses the critical challenge of limited access to specialist eye care by providing simple, implementable, and cost-effective diagnostic solutions. Their technology aims to bridge the gap between primary care and specialist assessment, making comprehensive eye screening available to more patients.
Features
- FDA-cleared Imaging Hardware: Proprietary optical technology for eye imaging
- AI-Based Screening: Automated detection of multiple retinal diseases
- Portable Design: Handheld device for flexible point-of-care use
- Multi-condition Detection: Screens for diabetic retinopathy, AMD, and glaucoma
Use Cases
- Primary care eye disease screening
- Optometry practices
- Retail health clinics
- Long-term care facilities
- Home health services
- Health system diagnostic services
FAQs
-
Is the Sentinel Camera FDA-cleared?
Yes, the Sentinel Camera is FDA-cleared for capturing digital images of the human eye. -
What conditions can Sentinel Pro detect?
Sentinel Pro is designed to identify and diagnose various retinal diseases, including Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma. -
Is Sentinel Pro FDA-cleared?
No, Sentinel Pro is not FDA-cleared and is currently only intended for investigational use.
